FNY Investment Advisers LLC Boosts Holdings in Oracle Corporation $ORCL

FNY Investment Advisers LLC lifted its stake in Oracle Corporation (NYSE:ORCL) by 126.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,379 shares of the enterprise software provider’s stock after buying an additional 4,121 shares during the period. FNY Investment Advisers LLC’s holdings in Oracle were worth $1,613,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of ORCL. Brighton Jones LLC grew its position in Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after purchasing an additional 100,494 shares during the last quarter. Revolve Wealth Partners LLC grew its position in Oracle by 8.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after purchasing an additional 404 shares during the last quarter. GAMMA Investing LLC grew its position in Oracle by 8.1% during the 1st quarter. GAMMA Investing LLC now owns 34,011 shares of the enterprise software provider’s stock worth $4,755,000 after purchasing an additional 2,546 shares during the last quarter. Advisor Resource Council purchased a new position in Oracle during the 1st quarter worth $328,000. Finally, Flagship Harbor Advisors LLC grew its position in Oracle by 5.0% during the 1st quarter. Flagship Harbor Advisors LLC now owns 12,097 shares of the enterprise software provider’s stock worth $1,691,000 after purchasing an additional 575 shares during the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.

Oracle Stock Down 0.7%

Shares of NYSE ORCL opened at $275.12 on Wednesday. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $345.72. The firm has a 50-day moving average price of $272.62 and a 200 day moving average price of $217.84. The stock has a market capitalization of $784.31 billion, a price-to-earnings ratio of 63.69, a price-to-earnings-growth ratio of 2.97 and a beta of 1.53.

Oracle (NYSE:ORCL) last announced its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. During the same quarter last year, the business earned $1.39 EPS. The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be paid a $0.50 dividend. The ex-dividend date is Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. Oracle’s dividend payout ratio (DPR) is 46.30%.

Analyst Upgrades and Downgrades

ORCL has been the topic of several research reports. William Blair reissued an “outperform” rating on shares of Oracle in a research report on Friday, October 17th. Barclays boosted their price target on shares of Oracle from $367.00 to $400.00 and gave the stock an “overweight” rating in a research note on Friday. UBS Group increased their price target on shares of Oracle from $360.00 to $380.00 and gave the stock a “buy” rating in a report on Friday. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $320.00 price objective on shares of Oracle in a report on Monday. Finally, Scotiabank increased their target price on Oracle from $350.00 to $360.00 and gave the stock an “outperform” rating in a research note on Friday. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $323.69.

Insider Transactions at Oracle

In related news, Director Naomi O. Seligman sold 2,222 shares of the firm’s stock in a transaction dated Friday, September 26th. The shares were sold at an average price of $288.91, for a total value of $641,958.02. Following the completion of the sale, the director owned 29,225 shares in the company, valued at $8,443,394.75. This trade represents a 7.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Stuart Levey sold 19,758 shares of Oracle stock in a transaction dated Friday, October 10th. The stock was sold at an average price of $300.00, for a total transaction of $5,927,400.00. Following the transaction, the executive vice president owned 18,429 shares of the company’s stock, valued at approximately $5,528,700. The trade was a 51.74% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 120,769 shares of company stock valued at $36,428,967. 40.90% of the stock is owned by company insiders.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.